机构：[1]State Key Laboratory of Oral Diseasesand National Clinical Research Centerfor Oral Diseases, West China Hospitalof Stomatology, Sichuan University,Chengdu, Sichuan, People’s Republic ofChina[2]Department of Head and NeckSurgery, Sichuan Cancer Hospital &Institute, Sichuan Cancer Center, Schoolof Medicine, University of ElectronicScience and Technology of China,Chengdu, Sichuan, People’s Republic ofChina四川省肿瘤医院[3]State Key Laboratory of MicrobialTechnology, Shandong University,Qingdao, Shandong, People’s Republic ofChina
With the rapid development of bioinformatics and gene sequencing technologies, understanding of circular RNAs (circRNAs) has been extended, and numerous studies have identified the key regulator role of circRNAs in a variety of diseases, especially in cancer. Recently, accumulated studies of oral squamous cell carcinoma (OSCC) have discovered the great potential of circRNAs, which can serve as prognostic or diagnostic biomarkers and affect the development and therapy of OSCC. In this review, we detail the new progress of circRNA research for OSCC in order to provide new strategies for clinical diagnosis and treatment.
基金：
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81972542, 81902779, 21838002]; National Science Foundation of Sichuan Province [2018JY0196, 2020JDRC0018, 2020YFS0171]
第一作者机构：[1]State Key Laboratory of Oral Diseasesand National Clinical Research Centerfor Oral Diseases, West China Hospitalof Stomatology, Sichuan University,Chengdu, Sichuan, People’s Republic ofChina
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Hua-yang Fan,Jian Jiang,Ya-jie Tang,et al.CircRNAs: A New Chapter in Oral Squamous Cell Carcinoma Biology[J].ONCOTARGETS AND THERAPY.2020,13:9071-9083.doi:10.2147/OTT.S263655.
APA：
Hua-yang Fan,Jian Jiang,Ya-jie Tang,Xin-hua Liang&Ya-ling Tang.(2020).CircRNAs: A New Chapter in Oral Squamous Cell Carcinoma Biology.ONCOTARGETS AND THERAPY,13,
MLA：
Hua-yang Fan,et al."CircRNAs: A New Chapter in Oral Squamous Cell Carcinoma Biology".ONCOTARGETS AND THERAPY 13.(2020):9071-9083
